Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Delgado

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 19, 2003
Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain traumaMario Delgado, Doina Ganea
Biochemical and Biophysical Research Communications|February 19, 2003
Vasoactive intestinal peptide inhibits IL-8 production in human monocytesMario Delgado, Doina Ganea
Journal of Cellular and Molecular Medicine|June 17, 2008
Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disordersPer Anderson, Mario Delgado
Biochemical and Biophysical Research Communications|February 27, 2003
Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by downregulating nuclear factor kappaB-dependent transcriptional activityMario Delgado, Doina Ganea
Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists|July 2, 2002
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunityDoina Ganea, Mario Delgado
Brain, Behavior, and Immunity|July 5, 2008
Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agentsMario Delgado, Doina Ganea
Brain, Behavior, and Immunity|September 11, 2007
Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cellsElena Gonzalez-Rey, Mario Delgado
ESC Heart Failure|April 12, 2026
Plasma Protein Profiles in Different Heart Failure PhenotypesLars Lind, Mario Delgado-Velandia
Trends in Molecular Medicine|May 1, 2007
Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasisElena Gonzalez-Rey, Mario Delgado
Drug News & Perspectives|November 3, 2006
Cortistatin as a potential multistep therapeutic agent for inflammatory disordersElena Gonzalez-Rey, Mario Delgado
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 19, 2003
Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain traumaMario Delgado, Doina Ganea
Biochemical and Biophysical Research Communications|February 19, 2003
Vasoactive intestinal peptide inhibits IL-8 production in human monocytesMario Delgado, Doina Ganea
Journal of Cellular and Molecular Medicine|June 17, 2008
Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disordersPer Anderson, Mario Delgado
Biochemical and Biophysical Research Communications|February 27, 2003
Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by downregulating nuclear factor kappaB-dependent transcriptional activityMario Delgado, Doina Ganea
Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists|July 2, 2002
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunityDoina Ganea, Mario Delgado
Brain, Behavior, and Immunity|July 5, 2008
Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agentsMario Delgado, Doina Ganea
Brain, Behavior, and Immunity|September 11, 2007
Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cellsElena Gonzalez-Rey, Mario Delgado
ESC Heart Failure|April 12, 2026
Plasma Protein Profiles in Different Heart Failure PhenotypesLars Lind, Mario Delgado-Velandia
Trends in Molecular Medicine|May 1, 2007
Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasisElena Gonzalez-Rey, Mario Delgado
Drug News & Perspectives|November 3, 2006
Cortistatin as a potential multistep therapeutic agent for inflammatory disordersElena Gonzalez-Rey, Mario Delgado
Pageof 18